The total return over the past 12 months is -26.05% vs. +16.94% for the S&P 500. So far it's up +24.14% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (26.05%) | (84.32%) | (70.37%) | (54.09%) | N/A | N/A |
| Total Return CAGR | (26.05%) | (84.32%) | (70.37%) | (54.09%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
BioVie Inc. (BIVI)
| Year | Start price | End price | BIVI Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.16 | $1.44 | +24.14% | +14.51% | +9.63% |
| 2025 | $20.00 | $1.16 | (94.20%) | +17.72% | (111.92%) |
| 2024 | $126.00 | $20.00 | (84.13%) | +24.89% | (109.02%) |
| 2023 | $777.00 | $126.00 | (83.78%) | +26.19% | (109.97%) |
| 2022 | $450.00 | $777.00 | +72.67% | (18.17%) | +90.84% |
| 2021 | $1,732.00 | $450.00 | (74.02%) | +28.74% | (102.76%) |
| 2020 | $350.00 | $1,732.00 | +394.86% | +18.37% | +376.49% |
| 2019 | $351.30 | $350.00 | (0.37%) | +31.22% | (31.59%) |
| 2018 | $1,875.00 | $351.30 | (81.26%) | (4.56%) | (76.70%) |
| 2017 | $3,687.50 | $1,875.00 | (49.15%) | +21.70% | (70.85%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
